アラバマ州における悪性黒色腫の臨床試験
アラバマ州内の拠点で、悪性黒色腫に関する12件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- University of Alabama at Birmingham: The Kirklin Clinic, Birmingham
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- University of Alabama at Birmingham Cancer Center, Birmingham
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- 他2件
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Alabama at Birmingham Cancer Center, Birmingham
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Alabama at Birmingham, Birmingham
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- The University of Alabama at Birmingham, Birmingham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07288112Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Alabama, Birmingham
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。